Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus - Wikidata - wikimedia - TriplyDB

Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus

Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus

http://www.wikidata.org/entity/Q34250473

about

Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices Alternative antimicrobial approach: nano-antimicrobial materials Vancomycin-modified Fe3O4@SiO2@Ag microflowers as effective antimicrobial agents.Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa.Antibacterial activity of gold-titanates on Gram-positive cariogenic bacteria Facile biofunctionalization of silver nanoparticles for enhanced antibacterial properties, endotoxin removal, and biofilm control.Study of the nucleation and growth of antibiotic labeled Au NPs and blue luminescent Au8 quantum clusters for Hg(2+) ion sensing, cellular imaging and antibacterial applications.Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins.New Synthesis of Gold- and Silver-Based Nano-Tetracycline Composites Prevention and treatment of Staphylococcus aureus biofilms.Multiple strategies to activate gold nanoparticles as antibiotics.Antimicrobial nanotechnology: its potential for the effective management of microbial drug resistance and implications for research needs in microbial nanotoxicology.Antimicrobial Activity of Gold Nanoparticles and Ionic Gold.Strategic role of selected noble metal nanoparticles in medicine.Fungi as an efficient mycosystem for the synthesis of metal nanoparticles: progress and key aspects of research.Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.Silver Nanocoating Technology in the Prevention of Prosthetic Joint Infection.Functionalization of nanostructures for antibiotic improvement: an interdisciplinary approach.Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect.Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria.Antimicrobial Nanomaterials: Why Evolution Matters.Nanomaterials for alternative antibacterial therapy.Bacterial resistance to silver nanoparticles and how to overcome it.Are antibiotic-functionalized nanoparticles a promising tool in antimicrobial therapies?Synthesis of 4-(dimethylamino)pyridine propylthioacetate coated gold nanoparticles and their antibacterial and photophysical activity.Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance.Silver nanoparticles functionalized with ampicillin.Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.Synthesis and Characterization of Cefotaxime Conjugated Gold Nanoparticles and Their Use to Target Drug-Resistant CTX-M-Producing Bacterial Pathogens.Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles.Antimicrobial hydrogels: promising materials for medical application.The gold/ampicillin interface at the atomic scale.Effect of Iron Oxide Nanoparticles and Amoxicillin on Bacterial Growth in the Presence of Dissolved Organic Carbon.Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii.Selective Photoinduced Antibacterial Activity of Amoxicillin-Coated Gold Nanoparticles: From One-Step Synthesis to in Vivo Cytocompatibility.Emerging and re-emerging infectious disease in otorhinolaryngology Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans"Magnetic fields suppressPseudomonas aeruginosabiofilms and enhance ciprofloxacin activity

P2860

Q26797497-666918E5-1930-4568-81FD-73BC51748371 Q28074875-6279467F-35B0-48D7-8744-724C8DC3FF9D Q28081490-C15DF444-45A6-44B0-A535-03937E4D9F08 Q33589402-BA9CB9E7-01C9-475D-87DC-8C8333130D07 Q33610519-AC51FB5F-BE9D-4D38-9D5E-2FE6290FEF86 Q33692222-93E5F254-6840-4356-BE2D-C6024C67F309 Q35209785-5676E145-EDE9-4F4A-905D-B1DE59798865 Q35840486-4551D63B-4BFE-4BE6-92C1-FBCA03A61D75 Q37361845-6CDB5C7A-017D-4870-AE4A-F48BE624C28D Q37458643-366553BA-58E7-4BA4-9088-DAD8EF64F0ED Q37482155-B48CC450-6E33-4D4C-803C-E259C8366964 Q38124738-346F81CD-2D8A-412D-B08E-B626E9510655 Q38193124-ED493C5D-037E-403B-ADAE-D1463C6F3AEB Q38527374-B7DBAE5F-92E7-4A44-8F3A-7525D4A476DA Q38531727-77074F1B-2E9B-4E1F-BEC6-06AF11C5EA8C Q38545443-AD014684-4B48-425C-A3B7-EB16D7F87F47 Q38762882-4C335C11-3142-418C-85A8-B3B8396E17A5 Q38841887-A5FB6809-F7AA-4874-99DC-9486051FDF45 Q38872187-165A6148-74AB-4734-BEB0-5CCC6D27D160 Q38993466-6FBE86EC-8EFC-422B-B58B-155F291FF4D9 Q42815902-161F78B7-2368-4B33-81A2-BCF28DE5BD74 Q42966513-88256E84-FB46-4235-9C16-BF0206BA46B9 Q46513006-505089BB-32CC-43CA-9BFA-57501BC0F8D0 Q47162724-1F6DEF3D-0E24-4FF9-A153-BB717CCEBD0B Q47331805-6EC66C98-C371-4F86-833F-E5CBB82E3600 Q47445988-B8C6D0E1-48B1-4C34-B6BF-FF82F1B5310E Q47697037-B46CA276-95C9-4811-BC9D-58680CF69E44 Q47727124-0EAFBAA1-B30E-4C41-97C4-CE970DF00627 Q48130276-CF5F0CC6-C64E-4B1C-900F-510BD15F9C17 Q50145801-2A0FB47C-098A-4012-AEFB-813812CD7AC6 Q53525114-A499310B-6ABD-4534-8000-DA40A3E49FDD Q53642909-A9FEC4E9-A00E-432E-82EE-D2DE1347DB9C Q53691449-4902779A-8491-4D8E-AFBC-2098D14CD131 Q53828574-D4001298-C3E5-4B58-B4B2-7E955C457987 Q55027395-EA61B0C5-74B2-4F1E-B606-3FF1DF78AD52 Q55378478-61B0F7B1-415D-4974-8967-08CB374611F8 Q55710323-F18A5B6A-CA34-4A24-9047-9009DC27B87A Q56904286-B11C82B6-43A3-4170-8F1C-C2EB92CD6EFD Q57177419-67E0F25E-3216-480A-B687-006B36D6BB15 Q57378228-4E66E096-B322-4948-A998-ABD6FD25A294

P2860

Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus

http://www.wikidata.org/entity/Q34250473

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@ast

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@en

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@nl

type

label

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@ast

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@en

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@nl

prefLabel

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@ast

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@en

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@nl

P1433

Q34250473-4B1C9D35-4233-4AA3-A425-9B72BA23919D

P1476

Q34250473-6D2D4DF0-51F4-4E4E-8CD6-F700A82FE288

P2093

Q34250473-01CD0574-11EB-48B9-8FCA-A8AE56D65823

Q34250473-9EC3518C-DF97-414F-A87E-9DA3A499FE02

Q34250473-9EC8DEA5-6CC9-4704-B804-F3273DEDC76D

Q34250473-9F6D65FC-0427-4496-B3C4-1E138CDB8CCA

Q34250473-EF6FF69D-8A2F-4405-9AAF-7854E0A0F69E

Q34250473-F0DBE24B-84EB-4001-A8B8-8AA8E0E9F02B

P2860

Q34250473-21930E4C-511C-4369-BB86-74006373C92F

Q34250473-22D9D98A-A69E-437E-A2DB-05C53919E010

Q34250473-26AB69A6-34A6-47A5-B3B2-80EB624AA0BC

Q34250473-29472F33-C3FA-47F8-8F97-14612EDBBAC5

Q34250473-36684B1F-1B0C-49B4-9B9D-BE38C5FFBD08

Q34250473-36DE56A2-8E3E-4184-9042-1176FFB73F69

Q34250473-36EC6350-A391-4BA5-AAA7-B54AA9954319

Q34250473-3F88290B-F64A-4F8E-965D-74D3C905D011

Q34250473-40E7FFAA-F854-475D-A6BC-8680C05BEA66

Q34250473-43748E06-82D9-4365-B51A-08F7FEC768A0

P304

Q34250473-4124273B-48BB-47B5-B103-067BFF5C7DC3

P31

Q34250473-4894BF71-9346-4EE8-97D6-0D0D674765D1

P356

Q34250473-C537B517-210B-4B06-9F83-B01D77CDC37F

P407

Q34250473-16839188-09BD-47AE-AEE2-944CC76178BF

P433

Q34250473-9B1C3A3E-DBAD-440B-AC2E-81D32C041511

P478

Q34250473-C59DFA39-FFDF-4BB8-99D0-1A8D5DB7C60A

P577

Q34250473-7BAF6A7C-103D-4188-8AED-E5E48BBF956C

P5875

Q34250473-F67E7019-67A6-4F17-BF6C-BB72EF0DB94B

P698

Q34250473-D4EE8B45-5492-4EED-959B-29C337F7D98A

P921

Q34250473-139D94A5-3B6B-44C0-B79B-591B81EA4DF9

Q34250473-24C6A0F2-7913-4FFB-9592-10945A396C4D

Q34250473-80604333-1C0C-4957-A1F6-CE65DF89C0ED

Q34250473-E775DEB0-AA17-416A-8075-629F7F936201

P932

Q34250473-0B61A723-0C6A-448C-8E77-C21B13F882A6

P356

P1433

Applied and Environmental Microbiology

P1476

Nanoparticles functionalized w ...... esistant Staphylococcus aureus

@en

P2093

Ashley N Brown

http://www.w3.org/2001/XMLSchema#string

Jiangrui Lu

http://www.w3.org/2001/XMLSchema#string

Kathryn Smith

http://www.w3.org/2001/XMLSchema#string

Maria E Scott

http://www.w3.org/2001/XMLSchema#string

Sherine O Obare

http://www.w3.org/2001/XMLSchema#string

Tova A Samuels

http://www.w3.org/2001/XMLSchema#string

P2860

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Surface-enhanced Raman imaging of intracellular bioreduction of chromate in Shewanella oneidensis.

The bactericidal effect of silver nanoparticles

Culture medium for enterobacteria

Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers.

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants

Challenges of antibacterial discovery

Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria.

Hemorrhagic colitis associated with a rare Escherichia coli serotype.

P304

2768-2774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AEM.06513-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221788620

http://www.w3.org/2001/XMLSchema#string

P698

22286985

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

antibiotic resistance

methicillin-resistant Staphylococcus aureus

P932

3318834

http://www.w3.org/2001/XMLSchema#string